Cogent Biosciences files SEC disclosure on Hovione supply agreement
Cogent Biosciences disclosed an agreement with Hovione in an SEC filing, covering entry into a commercial supply agreement effective Sept. 1, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.